Skip to main content
TrimSoMoEverything GLP-1, in one place
Clinical Appointment Preparation

GLP-1 Doctor Consultation & Lab Checklist

Maximize your 15-minute appointment with structured clinical baseline data.

Select the baseline lab tests you need, review critical FDA contraindication screens, and copy or print a formatted clinical brief for your physician or nurse practitioner.

Interactive Patient Tool

Doctor Discussion Checklist & Consultation Brief

Select essential baseline labs, FDA safety screenings, and clinical questions to discuss with your healthcare provider.

12 of 12 items selected
··

1. Baseline Metabolic Lab Panel (Recommended Before Starting)

Doctors require baseline organ function and blood sugar levels prior to initiating GLP-1 receptor agonists.

2. FDA Safety & Contraindication Self-Screening

Critical medical disclosures from official FDA prescribing labels that your clinician must review.

3. Practical Clinical Questions to Ask Your Prescriber

Proactive dialogue questions regarding medication interactions, titration tolerance, and long-term planning.

Ready for your telehealth consultation or in-person visit?Copy these selected points to paste directly into your portal intake form, or print a clinical reference sheet.

Clinical Communication Notice: This checklist compiles public FDA prescribing label guidance and professional clinical standards for personal educational organization. TrimSoMo is not a healthcare provider and does not provide medical consultations or diagnosis. Always discuss your personal medical history, current prescriptions, and laboratory results with your licensed healthcare provider.

1. The 4 Essential Baseline Lab Panels Explained

Before issuing an initial GLP-1 prescription, thorough clinical guidelines (including Obesity Medicine Association and Endocrine Society protocols) recommend ordering four baseline blood tests:

Kidney & Liver Status

Comprehensive Metabolic Panel (CMP)

Evaluates renal markers (eGFR, serum creatinine, BUN) and hepatic transaminases (ALT, AST). Because GLP-1 therapies frequently induce transient nausea or decreased fluid intake, establishing baseline kidney filtration is crucial to prevent acute kidney injury (AKI) from secondary dehydration.

Glycemic Control & Formularies

Hemoglobin A1c (HbA1c)

Measures your 90-day average blood sugar. If your A1c is ≥ 6.5%, you meet diagnostic criteria for Type 2 Diabetes, which dramatically expands insurance coverage options (e.g., Ozempic or Mounjaro on commercial formularies) compared to standalone obesity indications.

Cardiovascular & Pancreas Safety

Fasting Lipid Profile

Measures LDL, HDL, total cholesterol, and triglycerides. Significantly elevated triglycerides (> 500 mg/dL) represent an independent risk factor for acute pancreatitis; establishing baseline lipid counts helps your doctor safeguard pancreatic health.

Endocrine Screening

Thyroid Stimulating Hormone (TSH)

Screens for unmanaged primary hypothyroidism, which can cause secondary weight gain and lethargy. Correcting thyroid hormone deficiency is an essential prerequisite before starting metabolic therapy.

2. FDA Black Box Warnings & Absolute Contraindications

Every FDA-approved GLP-1 receptor agonist and dual GIP/GLP-1 agonist carries a boxed warning on its official prescribing label. Always disclose the following medical histories to your doctor:

Medullary Thyroid Carcinoma (MTC) & MEN 2: In rodent bioassays, semaglutide and tirzepatide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors. These medications are strictly contraindicated in individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2.
Prior Acute Pancreatitis: If you have a documented history of severe acute pancreatitis, your physician will evaluate whether alternative therapies are safer, as GLP-1 receptor stimulation has been associated with rare cases of acute pancreatitis.
Pregnancy & Nursing: GLP-1 therapies must be discontinued at least 2 months prior to a planned pregnancy due to prolonged elimination half-lives and potential fetal harm during organogenesis.

3. Critical Medication Interactions You Must Disclose

Oral Contraceptives (Birth Control)

Because tirzepatide (Zepbound) and semaglutide (Wegovy) delay gastric emptying, the absorption rate and peak plasma concentration of oral hormonal contraceptives can be diminished. FDA labeling advises using a non-oral or backup barrier method for 4 weeks after initiation and 4 weeks after every dose escalation.

Insulin Secretagogues (Sulfonylureas & Insulin)

GLP-1s lower blood glucose in a glucose-dependent manner, meaning they rarely cause hypoglycemia when taken alone. However, combining GLP-1s with exogenous insulin or sulfonylureas (e.g., glipizide, glimepiride) increases the risk of severe hypoglycemia. Prescribers typically reduce background insulin doses by 20%–50% upon GLP-1 initiation.

4. How to Structure Your 15-Minute Visit for Insurance Approval

Physicians are pressed for time during routine clinical visits. By handing them or reading from your formatted checklist, you help them document the specific clinical keywords PBM prior authorization reviewers look for:

Document Exact Baseline Weight & Height: Ensure the medical assistant records your vitals accurately in the EHR to establish the official qualifying BMI.
Code Comorbidities Explicitly: Ask your doctor to include ICD-10 diagnostic codes for hypertension (I10), hyperlipidemia (E78.5), or obstructive sleep apnea (G47.33) in the primary visit notes.
Verify Chart History of Lifestyle Interventions: Ensure your provider includes a line noting that you have attempted commercial or physician-supervised lifestyle and nutritional interventions over the preceding 6 months.
Appointment Preparation FAQs

Frequently Asked Questions About Doctor Visits

Do I really need bloodwork before starting Wegovy or Zepbound?↓

Yes. Most reputable clinicians and clinical guidelines recommend baseline bloodwork (especially a Comprehensive Metabolic Panel to check kidney/liver function, and an HbA1c to screen for glycemic abnormalities). Baseline labs establish safe reference points, ruling out kidney impairment or severe hypertriglyceridemia before therapy initiation.

What is the black box warning on GLP-1 receptor agonists?↓

All GLP-1 receptor agonists carry an FDA boxed warning regarding the risk of thyroid C-cell tumors based on rodent carcinogenicity studies. Semaglutide and tirzepatide are strictly contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Why does the checklist mention oral birth control pills?↓

Because GLP-1 medications delay gastric emptying, the rate of absorption of oral medications can be affected. The FDA prescribing information for Zepbound (tirzepatide) specifically advises female patients on oral contraceptives to switch to a non-oral contraceptive method or add a barrier method for 4 weeks after initiating therapy and for 4 weeks following each dose escalation.

Can my primary care physician (PCP) prescribe GLP-1s, or do I need an endocrinologist?↓

Any licensed medical doctor (MD/DO), nurse practitioner (NP), or physician assistant (PA) with prescribing authority can prescribe GLP-1 medications. However, board-certified obesity medicine specialists (ABOM) or endocrinologists may offer deeper experience in navigating complex prior authorizations, titrations, and plateau management.

How does this printable checklist help with insurance Prior Authorization (PA)?↓

Health insurers frequently deny GLP-1 prior authorizations due to missing baseline records—such as lack of documented baseline BMI, missing comorbidity codes (hypertension, sleep apnea, dyslipidemia), or absence of documented prior lifestyle modification attempts. Presenting this checklist ensures your doctor captures all necessary data points in the initial encounter note.

Next Decision Steps

Check Your Financial Options & Eligibility

Calculate expected copays under your insurance plan or test your BMI against FDA label criteria.